KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $1.8 million.

  • Staar Surgical's Free Cash Flow rose 17387.16% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.5 million, marking a year-over-year decrease of 25037.84%. This contributed to the annual value of -$7.7 million for FY2024, which is 11338.34% down from last year.
  • Per Staar Surgical's latest filing, its Free Cash Flow stood at $1.8 million for Q3 2025, which was up 17387.16% from -$29.0 million recorded in Q2 2025.
  • Staar Surgical's 5-year Free Cash Flow high stood at $28.9 million for Q4 2023, and its period low was -$29.0 million during Q2 2025.
  • Its 5-year average for Free Cash Flow is $295800.0, with a median of $364500.0 in 2022.
  • Per our database at Business Quant, Staar Surgical's Free Cash Flow plummeted by 25517.69% in 2022 and then skyrocketed by 283753.55% in 2023.
  • Quarter analysis of 5 years shows Staar Surgical's Free Cash Flow stood at $3.8 million in 2021, then crashed by 127.7% to -$1.1 million in 2022, then skyrocketed by 2837.54% to $28.9 million in 2023, then tumbled by 117.6% to -$5.1 million in 2024, then skyrocketed by 135.1% to $1.8 million in 2025.
  • Its Free Cash Flow was $1.8 million in Q3 2025, compared to -$29.0 million in Q2 2025 and -$7.2 million in Q1 2025.